Nutritional Supplement

Bilberry

  • Eye Health Support

    Glaucoma

    In a preliminary study, supplementation with a product that provided Pycnogenol (a maritime pine bark extract) and a standardized bilberry extract significantly decreased intraocular pressure in people who had elevated intraocular pressure.
    Glaucoma
    ×
    In a preliminary study, supplementation with a product that provided daily 80 mg of Pycnogenol (a maritime pine bark extract) and 160 mg of a standardized bilberry extract for two months significantly decreased intraocular pressure in people who had elevated intraocular pressure.12

    Retinopathy

    Bilberry extract has been shown to strengthen blood vessels in the eye and improve vision in people with diabetic and hypertensive retinopathy.
    Retinopathy
    ×

    Bilberry extracts standardized to contain 25% anthocyanosides have been suggested as a treatment for people with early-stage diabetic or hypertensive retinopathy. In a small preliminary trial, people with various types of retinopathy, including diabetic retinopathy and macular degeneration, were given 600 mg of bilberry extract per day for one month.13 While researchers found that the tendency to hemorrhage in the eye was reduced and that blood vessels were strengthened, there were no reports of improved vision. A small double-blind trial found that 160 mg of bilberry extract taken twice per day for one month led to similar improvements in blood-vessel health in the eye and slightly improved vision in people with diabetic and/or hypertensive retinopathy.14 Larger and longer clinical trials are needed to establish the effectiveness of bilberry for treating retinopathies.

    Macular Degeneration

    Supplementing with bilberry may help prevent and treat early-stage macular degeneration.
    Macular Degeneration
    ×
     

    Bilberry’s active flavonoid compounds, anthocyanosides, act as antioxidants in the retina of the eye. Therefore, supplementing with bilberry would theoretically be of value for the prevention or treatment of early-stage macular degeneration.15 Bilberry has also been shown to strengthen capillaries and to reduce bleeding in the retina.16 A typical amount of bilberry used in studies was 480–600 mg per day of an extract standardized to contain 25% anthocyanosides, taken in capsules or tablets.

    Glaucoma

    In a preliminary trial, supplementing with anthocyanins (flavonoids found in bilberry) improved symptoms in people with normal-tension glaucoma.
    Glaucoma
    ×
    In a preliminary trial, supplementing with anthocyanins (a group of flavonoids found in bilberry and certain other plant foods) improved visual acuity and partially reversed visual field damage in patients with normal-tension glaucoma (a type of glaucoma associated with normal intraocular pressure). The amount used was 60 mg twice a day for an average of two years.17

    Night Blindness

    Bilberry is high in flavonoids that speed the regeneration of the pigment used by eye for night vision. Supplementing with bilberry has been shown to improve dark adaptation in people with poor night vision.
    Night Blindness
    ×

    Bilberry, a close relative of the blueberry, is high in flavonoids known as anthocyanosides. Anthocyanosides speed the regeneration of rhodopsin, the purple pigment that is used by the rods in the eye for night vision.18 Supplementation with bilberry has been shown in early studies to improve dark adaptation in people with poor night vision.19,20 However, two newer studies found no effect of bilberry on night vision in healthy people.21,22 Bilberry extract standardized to contain 25% anthocyanosides may be taken in capsule or tablet form. Doctors typically recommend 240 to 480 mg per day.

    Cataracts

    Bilberry is high in flavonoids called anthocyanosides, which may protect both the lens and retina from oxidative damage and reduce the risk of cataracts.
    Cataracts
    ×
     

    Bilberry, a close relative of blueberry, is high in flavonoids called anthocyanosides.23 Anthocyanosides may protect both the lens and retina from oxidative damage. The potent antioxidant activity of anthocyanosides may make bilberry useful for reducing the risk of cataracts.24,25 Doctors sometimes recommend 240 to 480 mg per day of bilberry extract, capsules or tablets standardized to contain 25% anthocyanosides.

  • Blood Sugar and Diabetes Support

    Type 2 Diabetes

    Bilberry may improve glucose metabolism and lower the risk of some diabetic complications, such as diabetic retinopathy.
    Type 2 Diabetes
    ×
    Like other berries and darkly pigmented fruits and vegetables, bilberry (Vaccinium myrtillus) is rich in polyphenolic compounds called anthocyanins. Laboratory and animal studies suggest bilberry and anthocyanins can improve glucose metabolism and insulin sensitivity through multiple actions, including reducing inflammation and oxidative stress, inhibiting carbohydrate-digesting enzymes, and improving the gut microbiome.26,27,28 Eating a diet high in anthocyanins has been consistently found to be associated with lower risk of type 2 diabetes, and clinical evidence shows anthocyanins from bilberry or other berries, especially when taken with meals, can improve blood glucose control and insulin sensitivity in people with type 2 diabetes. In one study, a single 470 mg dose of standardized bilberry extract (36% anthocyanins) before eating reduced the post-meal increase in blood glucose in subjects with type 2 diabetes.29,30,31,32,33,34,35 Bilberry and anthocyanins may also help to prevent and treat some diabetic complications. For example, a growing body of evidence suggests bilberry and anthocyanins can improve microvascular health and retinal function in people with diabetic retinopathy.36

    Retinopathy

    Bilberry extract has been shown to strengthen blood vessels in the eye and improve vision in people with diabetic and hypertensive retinopathy.
    Retinopathy
    ×

    Bilberry extracts standardized to contain 25% anthocyanosides have been suggested as a treatment for people with early-stage diabetic or hypertensive retinopathy. In a small preliminary trial, people with various types of retinopathy, including diabetic retinopathy and macular degeneration, were given 600 mg of bilberry extract per day for one month.37 While researchers found that the tendency to hemorrhage in the eye was reduced and that blood vessels were strengthened, there were no reports of improved vision. A small double-blind trial found that 160 mg of bilberry extract taken twice per day for one month led to similar improvements in blood-vessel health in the eye and slightly improved vision in people with diabetic and/or hypertensive retinopathy.38 Larger and longer clinical trials are needed to establish the effectiveness of bilberry for treating retinopathies.

    Type 1 Diabetes

    Bilberry may lower the risk of some diabetic complications, such as diabetic cataracts and retinopathy.
    Type 1 Diabetes
    ×
    Animal research suggests bilberry extract may improve glycemic control and lower the risk of some diabetic complications, such as diabetic cataracts and retinopathy.39,40,41 Compounds called anthocyanins, found in bilberry and other dark berries, have strong antioxidant and anti-inflammatory effects that appear to mitigate some of the negative impacts of chronically elevated glucose levels.42,43 One preliminary trial found that supplementation with a standardized extract of bilberry improved signs of retinal damage in some people with diabetic retinopathy.44
  • Heart and Circulatory Health

    Atherosclerosis

    Bilberry has been shown to prevent platelet aggregation.
    Atherosclerosis
    ×
     

    Turmeric’s active compound curcumin has shown potent anti-platelet activity in animal studies.45 It has also demonstrated this effect in preliminary human studies.46 In a similar vein, bilberry has been shown to prevent platelet aggregation47 as has peony.48 However, none of these three herbs has been documented to help atherosclerosis in human trials.

    Edema

    Because coumarin, hydroxyethylrutosides, and diosmin are not widely available in, flavonoids such as anthocyanosides (from bilberry), have been substituted by doctors. The effects of these flavonoids against edema has not been well studied.
    Edema
    ×
    Because coumarin, hydroxyethylrutosides, and diosmin are not widely available in the United States, other flavonoids, such as quercetin, rutin, or anthocyanosides (from bilberry), have been substituted by doctors in an attempt to obtain similar benefits. The effect of these other flavonoids against edema has not been well studied. Also, optimal amounts are not known. However, in one study, quercetin in amounts of 30-50 mg per day corrected abnormal capillary permeability (leakiness),49 an effect that might improve edema. A similar effect has been reported with rutin at 20 mg three times per day.50 Doctors often recommend 80 to 160 mg of a standardized extract of bilberry, three times per day.
  • Healthy Aging/Senior Health

    Macular Degeneration

    Supplementing with bilberry may help prevent and treat early-stage macular degeneration.
    Macular Degeneration
    ×
     

    Bilberry’s active flavonoid compounds, anthocyanosides, act as antioxidants in the retina of the eye. Therefore, supplementing with bilberry would theoretically be of value for the prevention or treatment of early-stage macular degeneration.51 Bilberry has also been shown to strengthen capillaries and to reduce bleeding in the retina.52 A typical amount of bilberry used in studies was 480–600 mg per day of an extract standardized to contain 25% anthocyanosides, taken in capsules or tablets.

    Night Blindness

    Bilberry is high in flavonoids that speed the regeneration of the pigment used by eye for night vision. Supplementing with bilberry has been shown to improve dark adaptation in people with poor night vision.
    Night Blindness
    ×

    Bilberry, a close relative of the blueberry, is high in flavonoids known as anthocyanosides. Anthocyanosides speed the regeneration of rhodopsin, the purple pigment that is used by the rods in the eye for night vision.53 Supplementation with bilberry has been shown in early studies to improve dark adaptation in people with poor night vision.54,55 However, two newer studies found no effect of bilberry on night vision in healthy people.56,57 Bilberry extract standardized to contain 25% anthocyanosides may be taken in capsule or tablet form. Doctors typically recommend 240 to 480 mg per day.

  • Digestive Support

    Diarrhea

    Bilberry has been used traditionally in Germany for adults and children with diarrhea. Only dried berries or juice should be used—fresh berries may worsen diarrhea.
    Diarrhea
    ×
     

    Astringent herbs traditionally used for diarrhea include blackberry leaves, blackberry root bark, blueberry leaves, and red raspberry leaves.58 Raspberry leaves are high in tannins and, like blackberry, may relieve acute diarrhea. A close cousin of the blueberry, bilberry, has been used traditionally in Germany for adults and children with diarrhea.59 Only dried berries or juice should be used—fresh berries may worsen diarrhea.

    Cranesbill has been used by several of the indigenous tribes of North America to treat diarrhea. The tannins in cranesbill likely account for the anti-diarrheal activity60—although there has been little scientific research to clarify cranesbill’s constituents and actions.

What Are Star Ratings?
×
Reliable and relatively consistent scientific data showing a substantial health benefit.
Contradictory, insufficient, or preliminary studies suggesting a health benefit or minimal health benefit.
For an herb, supported by traditional use but minimal or no scientific evidence. For a supplement, little scientific support.

Our proprietary “Star-Rating” system was developed to help you easily understand the amount of scientific support behind each supplement in relation to a specific health condition. While there is no way to predict whether a vitamin, mineral, or herb will successfully treat or prevent associated health conditions, our unique ratings tell you how well these supplements are understood by the medical community, and whether studies have found them to be effective for other people.

For over a decade, our team has combed through thousands of research articles published in reputable journals. To help you make educated decisions, and to better understand controversial or confusing supplements, our medical experts have digested the science into these three easy-to-follow ratings. We hope this provides you with a helpful resource to make informed decisions towards your health and well-being.

Temp Title
×
Temp Text

Traditional Use (May Not Be Supported by Scientific Studies)

The dried berries and leaves of bilberry have been recommended for a wide variety of conditions, including scurvy, urinary tract infections, kidney stones, and diabetes. Perhaps the most sound historical application is the use of the dried berries to treat diarrhea. Modern research of bilberry was partly based on its use by British World War II pilots, who noticed that their night vision improved when they ate bilberry jam prior to night bombing raids.61

References

1. Sala D, Rolando M, Rossi PL, et al. Effect of anthocyanosides on visual performance at low illumination. Minerva Oftalmol 1979;21:283-5.

2. Jayle GE, Aubry M, Gavini H, et al. Study concerning the action of anthocyanoside extracts of Vaccinium myrtillus on night vision. Ann Ocul 1965;198:556-62 [in French].

3. Belleoud L, Leluan D, Boyer YS. Study on the effects of anthocyanin glycosides on the nocturnal vision of air controllers. Rev Med Aeronaut Spatiale 1966;18:3-7.

4. Zadok D, Levy Y, Glovinsky Y. The effect of anthocyanosides in a multiple oral dose on night vision. Eye 1999;13:734-6.

5. Muth ER, Laurent JM, Jasper P. The effect of bilberry nutritional supplementation on night visual acuity and contrast sensitivity. Altern Med Rev 2000;5:164-73.

6. Bravetti G. Preventive medical treatment of senile cataract with vitamin E and anthocyanosides: Clinical evaluation. Ann Ottalmol Clin Ocul 1989;115:109 [in Italian].

7. Perossini M, Guidi G, Chiellini S, Siravo D. Diabetic and hypertensive retinopathy therapy with Vaccinium myrtillus anthocyanosides (Tegens®): Double-blind placebo-controlled clinical trial. Ann Ottalmol Clin Ocul 1987;12:1173-90 [in Italian].

8. Scharrer A, Ober M. Anthocyanosides in the treatment of retinopathies. Klin Monatsblatt Augenheilk 1981;178:386–9.

9. Salvayre R, Braquet P, Perruchot T, DousteBlazy L. Comparison of the scavenger effect of bilberry anthocyanosides with various flavonoids. Proceed Intl Bioflavonoids Symposium, Munich, 1981, 437-42.

10. Boniface R, Miskulin M, Robert AM. Pharmacological properties of myrtillus anthocyanosides: Correlation with results of treatment of diabetic microangiopathy. In Flavonoids and Bioflavonoids, L Farkas, M Gabors, FL Kallay, eds. Ireland: Elsevier, 1985, 293-301.

11. Francesca Rasetti M, Caruso D, Galli G, et al. Extracts of Ginkgo biloba L. leaves and Vaccinium myrtillus L. fruits prevent photo induced oxidation of low density lipoprotein cholesterol. Phytomedicine 1997;3:335-8.

12. Steigerwalt RD, Gianni B, Paolo M, et al. Effects of Mirtogenol on ocular blood flow and intraocular hypertension in asymptomatic subjects. Mol Vis 2008;14:1288-92.

13. Scharrer A, Ober M. Anthocyanosides in the treatment of retinopathies. Klin Monatsblatt Augenheilk 1981;178:386–9.

14. Perossini M, Guidi G, Chiellini S, Siravo D. Diabetic and hypertensive retinopathy therapy with Vaccinium myrtillus anthocyanosides (Tegens®): Double-blind, placebo-controlled clinical trial. Ann Ottalmol Clin Ocul 1987;113:1173-7 [in Italian].

15. Scharrer A, Ober M. Anthocyanosides in the treatment of retinopathies. Klin Monatsblatt Augenheilk 1981;178:386–9.

16. Mian E, Curri SB, Lietti A, Bombardelli E. Anthocyanosides and the walls of microvessels: Further aspects of the mechanism of action of their protective in syndromes due to abnormal capillary fragility. Minerva Med 1977;68:3565-81.

17. Shim SH, Kim JM, Choi CY, et al. Ginkgo biloba extract and bilberry anthocyanins improve visual function in patients with normal tension glaucoma. J Med Food 2012;15:818-23.

18. Alfieri R, Sole P. Influencedes anthocyanosides admintres parvoie parenterale su l'adaptoelectroretinogramme du lapin. CR Soc Biol 1964;15:2338 [in French].

19. Jayle GE, Aubry M, Gavini H, et al. Study concerning the action of anthocyanoside extracts of Vaccinium myrtillus on night vision. Ann Ocul 1965;198:556-62 [in French].

20. Belleoud L, Leluan D, Boyer YS. Study on the effects of anthocyanin glycosides on the nocturnal vision of air controllers. Rev Med Aeronaut Spatiale 1966;18:3-7.

21. Zadok D, Levy Y, Glovinsky Y. The effect of anthocyanosides in a multiple oral dose on night vision. Eye 1999;13:734-6.

22. Muth ER, Laurent JM, Jasper P. The effect of bilberry nutritional supplementation on night visual acuity and contrast sensitivity. Altern Med Rev 2000;5:164-73.

23. Van Acker SA, van den Berg DJ, Tromp MN, et al. Structural aspects of antioxidant activity of flavonoids. Free Rad Biol Med1996; 20:331-42.

24. Salvayre R, Braquet P, Perruchot T, DousteBlazy L. Comparison of the scavenger effect of bilberry anthocyanosides with various flavonoids. Proceed Intl Bioflavonoids Symposium, Munich, 1981, 437-42.

25. Bravetti G. Preventive medical treatment of senile cataract with vitamin E and anthocyanosides: Clinical evaluation. Ann Ottalmol Clin Ocul 1989;115:109 [in Italian].

26. Guo H, Ling W. The update of anthocyanins on obesity and type 2 diabetes: experimental evidence and clinical perspectives. Rev Endocr Metab Disord 2015;16:1–13.

27. Rozanska D, Regulska-Ilow B. The significance of anthocyanins in the prevention and treatment of type 2 diabetes. Adv Clin Exp Med 2018;27:135–42.

28. Karcheva-Bahchevanska D, Lukova P, Nikolova M, et al. Effect of Extracts of Bilberries (Vaccinium myrtillus L.) on Amyloglucosidase and alpha-Glucosidase Activity. Folia Med (Plovdiv) 2017;59:197–202.

29. Guo X, Yang B, Tan J, et al. Associations of dietary intakes of anthocyanins and berry fruits with risk of type 2 diabetes mellitus: a systematic review and meta-analysis of prospective cohort studies. Eur J Clin Nutr 2016;70:1360–7.

30. Rocha D, Caldas A, da Silva B, et al. Effects of blueberry and cranberry consumption on type 2 diabetes glycemic control: A systematic review. Crit Rev Food Sci Nutr 2019;59:1816–28.

31. Burton-Freeman B, Brzezinski M, Park E, et al. A Selective Role of Dietary Anthocyanins and Flavan-3-ols in Reducing the Risk of Type 2 Diabetes Mellitus: A Review of Recent Evidence. Nutrients 2019;11.

32. Cao H, Ou J, Chen L, et al. Dietary polyphenols and type 2 diabetes: Human Study and Clinical Trial. Crit Rev Food Sci Nutr 2018:1-9.

33. Yang L, Ling W, Du Z, et al. Effects of Anthocyanins on Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Adv Nutr 2017;8:684–93.

34. de Mello V, Lankinen M, Lindstrom J, et al. Fasting serum hippuric acid is elevated after bilberry (Vaccinium myrtillus) consumption and associates with improvement of fasting glucose levels and insulin secretion in persons at high risk of developing type 2 diabetes. Mol Nutr Food Res 2017;61.

35. Hoggard N, Cruickshank M, Moar K, et al. A single supplement of a standardized bilberry (Vaccinium myrtillus L.) extract (36 % wet weight anthocyanins) modifies glycaemic response in individuals with type 2 diabetes controlled by diet and lifestyle. J Nutr Sci 2013;2:e22.

36. Ghosh D, Konishi T. Anthocyanins and anthocyanin-rich extracts: role in diabetes and eye function. Asia Pac J Clin Nutr 2007;16:200–8.

37. Scharrer A, Ober M. Anthocyanosides in the treatment of retinopathies. Klin Monatsblatt Augenheilk 1981;178:386–9.

38. Perossini M, Guidi G, Chiellini S, Siravo D. Diabetic and hypertensive retinopathy therapy with Vaccinium myrtillus anthocyanosides (Tegens®): Double-blind, placebo-controlled clinical trial. Ann Ottalmol Clin Ocul 1987;113:1173-7 [in Italian].

39. Petlevski R, Hadzija M, Slijepcevic M, Juretic D. Effect of 'antidiabetis' herbal preparation on serum glucose and fructosamine in NOD mice. J Ethnopharmacol 2001;75:181–4.

40. Stefanescu Braic R, Vari C, Imre S, et al. Vaccinium Extracts as Modulators in Experimental Type 1 Diabetes. J Med Food 2018;21:1106–12.

41. Kim J, Kim C, Lee Y, et al. Vaccinium myrtillus extract prevents or delays the onset of diabetes-induced blood-retinal barrier breakdown. Int J Food Sci Nutr 2015;66:236–42.

42. Putta S, Yarla N, Kumar K, et al. Preventive and Therapeutic Potentials of Anthocyanins in Diabetes and Associated Complications. Curr Med Chem 2018;25:5347–71.

43. Nabavi S, Habtemariam S, Daglia M, et al. Anthocyanins as a potential therapy for diabetic retinopathy. Curr Med Chem 2015;22:51–8.

44. Scharrer A, Ober M. Anthocyanosides in the treatment of retinopathies. Klin Monatsblatt Augenheilk 1981;178:386–9.

45. Srivastava R, Dikshit M, Srimal RC, Dhawan BN. Anti-thrombotic effect of curcumin. Thromb Res 1985;40:413-7.

46. Srivastava KC, Bordia A, Verma SK. Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets. Prost Leuk Essen Fat Acids. 1995;52:223-7.

47. Pulliero G, Montin S, et al. Ex vivo study of the inhibitory effects of Vaccinium myrtillus (bilberry) anthocyanosides on human platelet aggregation. Fitoterapia 1989;60:69-75.

48. Liu J. Effect of Paeonia obovata 801 on metabolism of thromboxane B2 and arachidonic acid and on platelet aggregation in patients with coronary heart disease and cerebral thrombosis. Chin Med J 1983;63:477-81 [in Chinese].

49. Griffith JQ. Clinical application of quercetin: preliminary report. J Am Pharm Assoc 1953;42:68-9.

50. Shanno RL. Rutin: a new drug for the treatment of increased capillary fragility. Am J Med Sci 1946;211:539-43.

51. Scharrer A, Ober M. Anthocyanosides in the treatment of retinopathies. Klin Monatsblatt Augenheilk 1981;178:386–9.

52. Mian E, Curri SB, Lietti A, Bombardelli E. Anthocyanosides and the walls of microvessels: Further aspects of the mechanism of action of their protective in syndromes due to abnormal capillary fragility. Minerva Med 1977;68:3565-81.

53. Alfieri R, Sole P. Influencedes anthocyanosides admintres parvoie parenterale su l'adaptoelectroretinogramme du lapin. CR Soc Biol 1964;15:2338 [in French].

54. Jayle GE, Aubry M, Gavini H, et al. Study concerning the action of anthocyanoside extracts of Vaccinium myrtillus on night vision. Ann Ocul 1965;198:556-62 [in French].

55. Belleoud L, Leluan D, Boyer YS. Study on the effects of anthocyanin glycosides on the nocturnal vision of air controllers. Rev Med Aeronaut Spatiale 1966;18:3-7.

56. Zadok D, Levy Y, Glovinsky Y. The effect of anthocyanosides in a multiple oral dose on night vision. Eye 1999;13:734-6.

57. Muth ER, Laurent JM, Jasper P. The effect of bilberry nutritional supplementation on night visual acuity and contrast sensitivity. Altern Med Rev 2000;5:164-73.

58. Tyler VE. Herbs of Choice: The Therapeutic Use of Phytomedicinals. New York: Pharmaceutical Products Press, 1994, 51-4.

59. Weiss RF. Herbal Medicine. Gothenburg, Sweden: Ab Arcanum and Beaconsfield, UK: Beaconsfield Publishers Ltd, 1988, 101-2.

60. Duke JA. CRC Handbook of Medicinal Plants. Boca Raton, FL: CRC Press, 1985, 209.

61. Brown DJ. Herbal Prescriptions for Health and Healing. Roseville, CA: Prima Health, 2000, 47-54.

62. Brown DJ. Herbal Prescriptions for Health and Healing. Roseville, CA: Prima Health, 2000, 47-54.

Copyright © 2024 TraceGains, Inc. All rights reserved.

Learn more about TraceGains, the company.

The information presented by TraceGains is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over the counter medication is also available. Consult your doctor, practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires December 2024.